13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001922318
Total reported value
$1.4B
$1.4B
52 檔
36.5%
As reported in its official Q1 2024 Form 13F filing, Pale Fire Capital SE's tracked investment portfolio stood at $1.4B with 52 total positions.
During Q1 2024, Pale Fire Capital SE's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
In terms of portfolio concentration, the top 5 core holdings (including SHEL, GRPN, DOLE) accounted for 36.5% of total reported equity market value during Q1 2024.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | SHEL | Shell Plc-adr | Stock-Energy | 24.66% | — | +13.97% | |
| 2 | GRPN | Groupon Inc | Stock-Other | 18.92% | +6.67% | +44.61% | |
| 3 | DOLE | Dole plc | Stock-Other | 12.74% | -2.69% | — | |
| 4 | INSW | International Seaways, Inc. | Stock-Other | 9.51% | — | +0.02% | |
| 5 | STNG | Scorpio Tankers Inc. | Stock-Other | 6.03% | — | -2.90% | |
| 6 | BABA | Alibaba Group Holding-sp Adr | Stock-Consumer Disc | 4.54% | +3.52% | NEW | |
| 7 | NMM | Navios Maritime Partners L.P. | Stock-Other | 4.16% | — | — | |
| 8 | CGAU | Centerra Gold Inc | Stock-Other | 2.45% | — | +64.42% | |
| 9 | ANGI1EUR | Angi Inc | Stock-Other | 2.18% | — | -4.75% | |
| 10 | TEN | Tsakos Energy Navigation Limited | Stock-Other | 1.87% | — | +16.42% | |
| 11 | TDOC | Teladoc Health Inc | Stock-Healthcare | 1.61% | -0.45% | +84.47% | |
| 12 | VOD | Vodafone Group Plc-sp Adr | Stock-Comm Services | 1.59% | — | +0.09% | |
| 13 | TNK | Teekay Tankers Ltd. | Stock-Other | 1.47% | — | — | |
| 14 | VAL | Valaris Limited | Stock-Energy | 1.37% | — | +1.01% | |
| 15 | NE | Noble Corporation plc | Stock-Energy | 1.26% | — | -31.26% | |
| 16 | NOMD | Nomad Foods Limited | Stock-Other | 1.14% | — | -36.29% | |
| 17 | DAR | Darling Ingredients Inc | Stock-Consumer Staples | 0.88% | — | +52.28% | |
| 18 | KGC | Kinross Gold CORP | Stock-Materials | 0.60% | — | — | |
| 19 | DO1USD | Diamond Offshore Drilling In | Stock-Other | 0.48% | — | — | |
| 20 | PPLI | People Inc | Stock-Comm Services | 0.42% | -0.19% | EXIT | |
| 21 | ORANY | Orange-spon Adr | Stock-Other | 0.41% | — | — | |
| 22 | CDLR | Cadeler A/s-adr | Stock-Other | 0.28% | — | -26.71% | |
| 23 | CVE | Cenovus Energy Inc | Stock-Energy | 0.28% | — | — | |
| 24 | ✓ | Stock-Other | 0.26% | — | — | ||
| 25 | DHC | Diversified Healthcare Trust | Stock-Other | 0.18% | — | — | |
| 26 | MOMO | Hello Group Inc -spn Adr | Stock-Other | 0.09% | — | — | |
| 27 | FVICHF | Fortuna Silver Mines Inc | Stock-Other | 0.07% | — | — | |
| 28 | RNW | ReNew Energy Global Plc | Stock-Other | 0.06% | — | -12.16% | |
| 29 | MLYS | Mineralys Therapeutics Inc | Stock-Other | 0.05% | +0.30% | -16.77% | |
| 30 | QURE | uniQure N.V. | Stock-Other | 0.05% | — | — | |
| 31 | CMPX | Compass Therapeutics Inc | Stock-Other | 0.03% | — | -30.43% | |
| 32 | ERAS | Erasca Inc | Stock-Other | 0.03% | — | -39.87% | |
| 33 | CELC | Celcuity Inc | Stock-Other | 0.03% | — | -28.73% | |
| 34 | ✓ | Passage Bio Inc | Stock-Other | 0.03% | — | -75.67% | |
| 35 | ATYR | Atyr Pharma Inc | Stock-Other | 0.02% | — | -68.94% | |
| 36 | TCRX | Tscan Therapeutics Inc | Stock-Other | 0.02% | — | — | |
| 37 | BDTX | Black Diamond Therapeutics I | Stock-Other | 0.02% | — | -34.06% | |
| 38 | MNKD | Mannkind CORP | Stock-Other | 0.02% | — | +48.40% | |
| 39 | IOVA | Iovance Biotherapeutics Inc | Stock-Other | 0.02% | — | -35.39% | |
| 40 | PRLD | Prelude Therapeutics Inc | Stock-Other | 0.02% | — | -50.49% | |
| 41 | AVXL | Anavex Life Sciences CORP | Stock-Other | 0.02% | — | — | |
| 42 | 1K0 | Igm Biosciences Inc | Stock-Other | 0.02% | — | — | |
| 43 | CRBU | Caribou Biosciences Inc | Stock-Other | 0.02% | — | -23.05% | |
| 44 | CMRXEUR | Chimerix Inc | Stock-Other | 0.02% | — | -50.38% | |
| 45 | RVNCEUR | Revance Therapeutics Inc | Stock-Other | 0.01% | — | — | |
| 46 | ✓ | Reviva Pharmaceutcls Hldgs I | Stock-Other | 0.01% | — | — | |
| 47 | HUMA | Humacyte Inc | Stock-Other | 0.01% | — | -30.84% | |
| 48 | ✓ | Cidara Therapeutics Inc Com New | Stock-Other | 0.01% | — | — | |
| 49 | PBYI | Puma Biotechnology Inc | Stock-Other | 0.01% | — | — | |
| 50 | ASNSUSD | X4 Pharmaceuticals Inc | Stock-Other | 0.01% | — | — |
According to official SEC Form 13F filings, Pale Fire Capital SE reported a total U.S. public equity portfolio value of $1.4B across 52 disclosed positions in Q1 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
During Q1 2024, Pale Fire Capital SE's top holdings by market value included SHEL (24.7%)、GRPN (18.9%)、DOLE (12.7%). The largest single position, SHEL, represented 24.7% of total portfolio value.
In Q1 2024, Pale Fire Capital SE made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.